Global Needles Market Growth, Share, Size, Trends and Forecast (2025 - 2031)

By Delivery Site;

Intradermal, Subcutaneous, Intravenous, ntramuscular, and Intraperitoneal.

By Product;

Suture, Blood Collection, and Insufflation.

By Application;

Pen Needles in Diabetes, Blood Collection Needles, Surgical Sutures Needles, Ophthalmic Procedure Needles, Dentistry Needle, Insufflation Needle, and Others.

By Geography;

North America, Europe, Asia Pacific, Middle East and Africa, and Latin America - Report Timeline (2021 - 2031).
Report ID: Rn121165853 Published Date: February, 2025 Updated Date: March, 2025

Introduction

Global Needles Market (USD Million), 2021 - 2031

In the year 2024, the Global Needles Market was valued at USD 7,130.57 million. The size of this market is expected to increase to USD 10,792.74 million by the year 2031, while growing at a Compounded Annual Growth Rate (CAGR) of 6.1%.

The Global Needles Market stands as a cornerstone within the broader healthcare industry, providing essential tools that are integral to a vast array of medical procedures, diagnostics, and therapeutic interventions. Needles, in their myriad forms, serve as fundamental medical devices utilized across diverse healthcare settings worldwide. From hospitals and clinics to ambulatory surgical centers, diagnostic laboratories, and even home healthcare environments, needles play a pivotal role in facilitating critical aspects of patient care, diagnostics, and treatment delivery.

At its core, the Global Needles Market encompasses a vast array of needle types, each tailored to specific medical applications and requirements. Traditional hypodermic needles, intravenous catheters, biopsy needles, spinal needles, and specialized surgical needles are just a few examples of the diverse range of needle products available in the market. These products are designed to address the unique needs of healthcare professionals across various medical specialties, including general medicine, surgery, anesthesia, oncology, cardiology, and more.

The importance of needles in healthcare delivery cannot be overstated. These devices serve as the primary means for administering medications, vaccines, and therapeutic agents, facilitating the accurate and precise delivery of pharmaceuticals into the body. Needles are essential for collecting biological samples such as blood, tissue, and fluids, enabling diagnostic testing, disease monitoring, and treatment assessment. Additionally, needles are instrumental in performing minimally invasive procedures, biopsies, aspirations, and injections, offering patients less invasive treatment options and faster recovery times.

In recent years, the market has witnessed significant advancements and innovations driven by technological developments, material advancements, and evolving healthcare needs. From the introduction of safety-engineered needles to reduce needlestick injuries to the development of specialty needles for advanced medical procedures, the market continues to evolve to meet the ever-changing demands of healthcare delivery. The increasing prevalence of chronic diseases, the rising demand for minimally invasive procedures, and the growing emphasis on patient safety and infection control have further fueled market growth and innovation in needle technologies.

  1. Introduction
    1. Research Objectives and Assumptions
    2. Research Methodology
    3. Abbreviations
  2. Market Definition & Study Scope
  3. Executive Summary
    1. Market Snapshot, By Delivery Site
    2. Market Snapshot, By Product
    3. Market Snapshot, By Application
    4. Market Snapshot, By Region
  4. Global Needles Market Dynamics
    1. Drivers, Restraints and Opportunities
      1. Drivers
        1. Rising chronic disease prevalence
        2. Demand for minimally invasive procedures
        3. Growing geriatric population
        4. Patient safety importance
        5. Point-of-care diagnostics adoption
      2. Restraints
        1. Regulatory hurdles
        2. Limited healthcare access
        3. Needlestick injury concerns
        4. Sterilization and waste issues
        5. Skilled professional shortages
      3. Opportunities
        1. Safety needle tech development
        2. Real-time smart needle adoption
        3. Needle-free drug delivery
        4. Tailored needle solutions
        5. Telemedicine needle integration
    2. PEST Analysis
      1. Political Analysis
      2. Economic Analysis
      3. Social Analysis
      4. Technological Analysis
    3. Porter's Analysis
      1. Bargaining Power of Suppliers
      2. Bargaining Power of Buyers
      3. Threat of Substitutes
      4. Threat of New Entrants
      5. Competitive Rivalry
  5. Market Segmentation
    1. Global Needles Market, By Delivery Site, 2021 - 2031 (USD Million)
      1. Intradermal
      2. Subcutaneous
      3. Intravenous
      4. ntramuscular
      5. Intraperitoneal
    2. Global Needles Market, By Product 2021 - 2031 (USD Million)
      1. Suture
      2. Blood Collection
      3. Insufflation
    3. Global Needles Market, By Application, 2021 - 2031 (USD Million)
      1. Pen Needles in Diabetes
      2. Blood Collection Needles
      3. Surgical Sutures Needles
      4. Ophthalmic Procedure Needles
      5. Dentistry Needle
      6. Insufflation Needle
      7. Others
  6. Global Needles Market, By Geography, 2021 - 2031 (USD Million)
    1. North America
      1. United States
      2. Canada
    2. Europe
      1. Germany
      2. United Kingdom
      3. France
      4. Italy
      5. Spain
      6. Nordic
      7. Benelux
      8. Rest of Europe
    3. Asia Pacific
      1. Japan
      2. China
      3. India
      4. Australia & New Zealand
      5. South Korea
      6. ASEAN (Association of South East Asian Countries)
      7. Rest of Asia Pacific
    4. Middle East & Africa
      1. GCC
      2. Israel
      3. South Africa
      4. Rest of Middle East & Africa
    5. Latin America
      1. Brazil
      2. Mexico
      3. Argentina
      4. Rest of Latin America
  7. Competitive Landscape
    1. Company Profiles
      1. Medtronic (Ireland)
      2. Ethicon US, LLC. (U.S.)
      3. Thermo Fisher Scientific Inc. (U.S.)
      4. Novo Nordisk A/S (Denmark), BD (U.S.)
      5. Stryker (U.S.)
      6. Boston Scientific Corporation (U.S.)
      7. Luminex Corporation ((U.S.)
      8. Illumina, Inc (U.S.)
      9. Bio-Rad Laboratories, Inc. (U.S.)
      10. QIAGEN (Netherlands)
      11. Abcam plc (U.K.)
      12. Merck KGaA (Germany)
      13. Promega Corporation (U.S.)
      14. Siemens (Germany)
      15. PerkinElmer, Inc. (U.S.)
      16. Shimadzu Corporation (Japan)
  8. Analyst Views
  9. Future Outlook of the Market